Phase II/III Study of Anti-VEGF in Neovascular AMD

Clinical trial NCT00021736 · COMPLETED

Trial details

NCT number: NCT00021736
Sponsor: Eyetech Pharmaceuticals
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Macular Degeneration Choroidal Neovascularization

Start date: 2001-07-01
Enrollment: 540

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.